Skip to content

CorMedix CRMD Total Liabilities

Total Liabilities at other companies

Pfizer logo
PfizerPFE
$3.41B-97.1%
Merck & Co. logo
Merck & Co.MRK
$229M
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1.09B+5.1%
ITG
Integer HoldingsITGR
$1.71B+1.4%
IAR
Integra LifeSciencesIART
$2.54B+0.3%
Emergent Biosolutions logo
Emergent BiosolutionsEBS
$13.3M+98.5%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's total liabilities?
CorMedix (CRMD) reported total liabilities of $378.59M in Q1 2026.
How has CorMedix's total liabilities changed year-over-year?
CorMedix's total liabilities increased by 991.2% year-over-year, from $34.69M to $378.59M.
What is the long-term trend for CorMedix's total liabilities?
Over 5 years (2020 to 2025), CorMedix's total liabilities has grown at a 141.9% compound annual growth rate (CAGR), from $5.09M to $420.84M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.